140 related articles for article (PubMed ID: 28075069)
1. Ebola Vaccination Using a DNA Vaccine Coated on PLGA-PLL/γPGA Nanoparticles Administered Using a Microneedle Patch.
Yang HW; Ye L; Guo XD; Yang C; Compans RW; Prausnitz MR
Adv Healthc Mater; 2017 Jan; 6(1):. PubMed ID: 28075069
[TBL] [Abstract][Full Text] [Related]
2. Effective humoral immune response from a H1N1 DNA vaccine delivered to the skin by microneedles coated with PLGA-based cationic nanoparticles.
Seok H; Noh JY; Lee DY; Kim SJ; Song CS; Kim YC
J Control Release; 2017 Nov; 265():66-74. PubMed ID: 28434892
[TBL] [Abstract][Full Text] [Related]
3. DNA vaccination via RALA nanoparticles in a microneedle delivery system induces a potent immune response against the endogenous prostate cancer stem cell antigen.
Cole G; Ali AA; McErlean E; Mulholland EJ; Short A; McCrudden CM; McCaffrey J; Robson T; Kett VL; Coulter JA; Dunne NJ; Donnelly RF; McCarthy HO
Acta Biomater; 2019 Sep; 96():480-490. PubMed ID: 31299353
[TBL] [Abstract][Full Text] [Related]
4. Microneedle-mediated transcutaneous immunization with plasmid DNA coated on cationic PLGA nanoparticles.
Kumar A; Wonganan P; Sandoval MA; Li X; Zhu S; Cui Z
J Control Release; 2012 Oct; 163(2):230-9. PubMed ID: 22921518
[TBL] [Abstract][Full Text] [Related]
5. Surface-assembled poly(I:C) on PEGylated PLGA microspheres as vaccine adjuvant: APC activation and bystander cell stimulation.
Hafner AM; Corthésy B; Textor M; Merkle HP
Int J Pharm; 2016 Nov; 514(1):176-188. PubMed ID: 27863662
[TBL] [Abstract][Full Text] [Related]
6. Immune responses to vaccines delivered by encapsulation into and/or adsorption onto cationic lipid-PLGA hybrid nanoparticles.
Liu L; Ma P; Wang H; Zhang C; Sun H; Wang C; Song C; Leng X; Kong D; Ma G
J Control Release; 2016 Mar; 225():230-9. PubMed ID: 26826307
[TBL] [Abstract][Full Text] [Related]
7. Microneedle arrays for vaccine delivery: the possibilities, challenges and use of nanoparticles as a combinatorial approach for enhanced vaccine immunogenicity.
Rodgers AM; Cordeiro AS; Kissenpfennig A; Donnelly RF
Expert Opin Drug Deliv; 2018 Sep; 15(9):851-867. PubMed ID: 30051726
[TBL] [Abstract][Full Text] [Related]
8. Surface-functionalized, pH-responsive poly(lactic-co-glycolic acid)-based microparticles for intranasal vaccine delivery: Effect of surface modification with chitosan and mannan.
Li Z; Xiong F; He J; Dai X; Wang G
Eur J Pharm Biopharm; 2016 Dec; 109():24-34. PubMed ID: 27569030
[TBL] [Abstract][Full Text] [Related]
9. In vivo evidence of oral vaccination with PLGA nanoparticles containing the immunostimulant monophosphoryl lipid A.
Sarti F; Perera G; Hintzen F; Kotti K; Karageorgiou V; Kammona O; Kiparissides C; Bernkop-Schnürch A
Biomaterials; 2011 Jun; 32(16):4052-7. PubMed ID: 21377204
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary delivery of DNA encoding Mycobacterium tuberculosis latency antigen Rv1733c associated to PLGA-PEI nanoparticles enhances T cell responses in a DNA prime/protein boost vaccination regimen in mice.
Bivas-Benita M; Lin MY; Bal SM; van Meijgaarden KE; Franken KL; Friggen AH; Junginger HE; Borchard G; Klein MR; Ottenhoff TH
Vaccine; 2009 Jun; 27(30):4010-7. PubMed ID: 19389445
[TBL] [Abstract][Full Text] [Related]
11. CD40-targeted dendritic cell delivery of PLGA-nanoparticle vaccines induce potent anti-tumor responses.
Rosalia RA; Cruz LJ; van Duikeren S; Tromp AT; Silva AL; Jiskoot W; de Gruijl T; Löwik C; Oostendorp J; van der Burg SH; Ossendorp F
Biomaterials; 2015 Feb; 40():88-97. PubMed ID: 25465442
[TBL] [Abstract][Full Text] [Related]
12. Stabilizer-free poly(lactide-co-glycolide) nanoparticles for multimodal biomedical probes.
Cheng FY; Wang SP; Su CH; Tsai TL; Wu PC; Shieh DB; Chen JH; Hsieh PC; Yeh CS
Biomaterials; 2008 May; 29(13):2104-12. PubMed ID: 18276001
[TBL] [Abstract][Full Text] [Related]
13. Efficient nanoparticle-mediated needle-free transcutaneous vaccination via hair follicles requires adjuvantation.
Mittal A; Schulze K; Ebensen T; Weißmann S; Hansen S; Lehr CM; Guzmán CA
Nanomedicine; 2015 Jan; 11(1):147-54. PubMed ID: 25200611
[TBL] [Abstract][Full Text] [Related]
14. PLGA-dendron nanoparticles enhance immunogenicity but not lethal antibody production of a DNA vaccine against anthrax in mice.
Ribeiro S; Rijpkema SG; Durrani Z; Florence AT
Int J Pharm; 2007 Mar; 331(2):228-32. PubMed ID: 17258876
[TBL] [Abstract][Full Text] [Related]
15. In vivo studies investigating biodistribution of nanoparticle-encapsulated rhodamine B delivered via dissolving microneedles.
Kennedy J; Larrañeta E; McCrudden MTC; McCrudden CM; Brady AJ; Fallows SJ; McCarthy HO; Kissenpfennig A; Donnelly RF
J Control Release; 2017 Nov; 265():57-65. PubMed ID: 28428065
[TBL] [Abstract][Full Text] [Related]
16. Lipid core peptide/poly(lactic-co-glycolic acid) as a highly potent intranasal vaccine delivery system against Group A streptococcus.
Marasini N; Khalil ZG; Giddam AK; Ghaffar KA; Hussein WM; Capon RJ; Batzloff MR; Good MF; Skwarczynski M; Toth I
Int J Pharm; 2016 Nov; 513(1-2):410-420. PubMed ID: 27659862
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B DNA vaccine-polycation nano-complexes enhancing immune response by percutaneous administration with microneedle.
Yin D; Liang W; Xing S; Gao Z; Zhang W; Guo Z; Gao S
Biol Pharm Bull; 2013; 36(8):1283-91. PubMed ID: 23676787
[TBL] [Abstract][Full Text] [Related]
18. Poly(lactic-co-glycolic acid) nanoparticles as candidate DNA vaccine carrier for oral immunization of Japanese flounder (Paralichthys olivaceus) against lymphocystis disease virus.
Tian J; Yu J
Fish Shellfish Immunol; 2011 Jan; 30(1):109-17. PubMed ID: 20920584
[TBL] [Abstract][Full Text] [Related]
19. Development and characterization of surface modified PLGA nanoparticles for nasal vaccine delivery: effect of mucoadhesive coating on antigen uptake and immune adjuvant activity.
Pawar D; Mangal S; Goswami R; Jaganathan KS
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):550-9. PubMed ID: 23831265
[TBL] [Abstract][Full Text] [Related]
20. Synthetic long peptide-based vaccine formulations for induction of cell mediated immunity: A comparative study of cationic liposomes and PLGA nanoparticles.
Varypataki EM; Silva AL; Barnier-Quer C; Collin N; Ossendorp F; Jiskoot W
J Control Release; 2016 Mar; 226():98-106. PubMed ID: 26876760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
